A treat to target approach for all patients with juvenile idiopathic arthritis should be able to achieve a 50% improvement in disease activity within three months and a target of clinical inactive disease within six months. This is one of eight recommendations by an international task force of paediatric rheumatologists, following a systematic review of ...
New guidelines for treating JIA to target
By Mardi Chapman
18 Apr 2018